جستجوی استاد راهنمای دانشگاهی

Andre Levchenkoمشاهده پروفایل

استاد

• Systems Biology
• Signal Transduction
• Cell Communication
• +۵ مورد دیگر

Andre Levchenko is the John C. Malone Professor of Biomedical Engineering at Yale University, with secondary appointments in the Department of Neurosurgery and affiliations with the Cancer Signaling Networks, Immunology, and the Yale Program in Neurodevelopment and Regeneration. His research focuses on systems biology, signal transduction, and cell-cell communication, utilizing microfluidics and computational modeling to study cancer progression, stem cell behavior, and neurological disorders. PhD, Columbia University MEng, Moscow Institute of Physics and Technology Levchenko's work explores how cells process dynamic signals to make critical decisions, particularly in glioblastoma migration, organoid development, and cardiovascular tissue engineering. His lab develops innovative microfluidic platforms and mathematical models to dissect multicellular communication and signaling networks. Recent publications highlight his contributions to understanding YAP-driven cancer invasion , NOTCH signaling in angiogenesis , and metabolic regulation of hypoxia responses . He has pioneered methods for organoid modeling and single-cell analysis , advancing precision in biological signaling studies. Scientific Awards : Computational Molecular Biology Post-Doctoral Fellowship (Burroughs Wellcome Fund) National Academies Keck Futures Conference Invitee Distinguished Guest Lecturer, University of Virginia American Asthma Foundation Early Excellence Award Fellow, American Institute for Medical and Biological Engineering Levchenko leads the Levchenko Lab at the Yale Systems Biology Institute, collaborating with institutions like Mayo Clinic and Yale Cancer Center. His research has received recognition in Faculty of 1000 and multiple journal highlights.

Waldemar Kolanusمشاهده پروفایل

استاد

• Molecular Immunology
• Cell Signaling
• Signal Transduction Pathways
• +۴ مورد دیگر

Prof. Waldemar Kolanus leads the Molecular Immunology and Cell Biology department at the University of Bonn's Life & Medical Sciences Institute (LIMES) . His research bridges immunoregulation , stem cell dynamics , and metabolic stress responses in immune cells. Unit 2 member at LIMES Principal investigator in SFB 704 and ImmunoSensation Cluster Leads a multidisciplinary lab with postdocs, PhD students, and technical staff His work focuses on intracellular signaling pathways connecting immune activation to tissue homeostasis, particularly through: Cytohesin proteins in integrin-mediated adhesion and migration TRIM71 in stem cell regulation and congenital hydrocephalus High-salt environments affecting macrophage function Publication trends show expertise in immune cell migration , genetic models , and chemical inhibition , with frequent use of mice and zebrafish for in vivo studies. Key articles explore: TRIM71's dual role in auditory development and germ cell maintenance Cytohesin family's Golgi regulation and insulin signaling Ruxolitinib's off-target migration inhibition of dendritic cells Contact details: Address: LIMES Institute, Carl-Troll-Straße 31, Bonn Email: kolanus.sekretariat@uni-bonn.de Phone: +49 228 73-62788

• Medical Genetics
• Nephrology
• Genomics
• +۳ مورد دیگر

Dr. Ian Wilson is a researcher at Newcastle University with a focus on medical genetics, nephrology, and genomic analysis. His work spans genetic determinants of kidney diseases, mitochondrial disorders, and biomarker development. Notable contributions include studies on uromodulin genetics in African populations, copy-number variations in rare diseases, and kidney ciliopathies. He has collaborated extensively on projects involving genome sequencing, mitochondrial replacement therapy, and muscular dystrophy biomarkers. Wilson's research integrates computational tools like machine learning for predictive modeling in urolithiasis and employs advanced imaging techniques for disease progression monitoring. Key areas: Genetic epidemiology, renal genomics, mitochondrial DNA analysis Focus on translational applications: Biomarker development for kidney stones and muscular dystrophies Interdisciplinary collaborations in ophthalmology and orthopedics His publications reflect a commitment to advancing diagnostic accuracy and understanding complex genetic disorders through multi-omics approaches.

Jeffrey Guastoمشاهده پروفایل

دانشیار

• Biophysics
• Soft Matter Physics
• Microscale Fluid Mechanics
• +۵ مورد دیگر

Jeffrey Guasto , Associate Professor at Tufts University, holds joint appointments in the School of Engineering (Mechanical Engineering) and School of Arts and Sciences (Physics & Astronomy). His work bridges engineering, physics, and biology to study transport properties in complex systems. Ph.D., Engineering (2009), Brown University Sc.M., Engineering (2004), Brown University Dual B.S. in Physics and Mechanical Engineering (2003), Lehigh University Research Interests focus on: Biophysics : Flagellar mechanics, chemotaxis, cell-fluid interactions Soft Matter : Active suspensions, colloids, viscoelastic materials Microfluidics : Device design for cell motility studies and gradient generation Environmental Transport : Microbial ecology in porous systems Scientific Trends from his 77+ publications show emphasis on microscale fluid dynamics, bacterial transport mechanisms, and viscoelastic flow instabilities. His 2024 Nature Microbiology work reveals phage-infected bacteria driving marine chemotaxis, while 2023 PNAS research explores stress topology in viscoelastic flows. Scientific Awards : NSF CAREER Award (2016) for cell dispersal mechanisms Collaborative NSF grants (2015-2023) Advising includes mentoring 15+ students and postdocs. His grants portfolio features 9+ awards, notably NSF grants for viral-microbe interactions (2018) and flagellar mechanics (2020). Labs & Teams : Leads the Guasto Laboratory at Tufts, integrating microfluidics and high-speed imaging for studying microbial transport, while collaborating with MIT, Harvard, and international institutions.

• Biochemistry
• Cell Biology
• Pharmacology
• +۵ مورد دیگر

Lonny R. Levin is a Professor of Pharmacology at Weill Cornell Medical College , where he has worked since 2009. Collaborating extensively with Dr. Jochen Buck, he pioneered research on bicarbonate-regulated soluble adenylyl cyclase (sAC) , a critical enzyme in cAMP signaling. Education : B.S. from Cornell University (1983), Ph.D. from State University of New York at Stony Brook (1989) His research focuses on: cAMP signaling microdomains in mammalian cells Mitochondrial metabolism and pH sensing Sperm capacitation and energy regulation Nonhormonal contraceptive development via sAC inhibition Recent publications (2025-2023) highlight: Structural insights into sAC activation Metabolic adaptations during sperm capacitation Emerging role in corneal endothelium signaling Drug discovery for on-demand male contraception Grants from NIH (NIAID, NICHD) support his work on: Intravaginal rings for dual HIV/herpes prevention and contraception Metabolic communication in reproductive systems Signalosome regulation in mitochondria He maintains collaborations with institutions like EMD Millipore Corporation and co-founded Sacyl Pharmaceuticals, Inc. , holding proprietary interests in sAC-related intellectual property.

Philipp Neumannمشاهده پروفایل

استاد

• High-Performance Computing
• Scientific Computing
• Parallel and Distributed Systems
• +۴ مورد دیگر

Philipp Neumann is a Professor and Chair of High-Performance Computing at Helmut Schmidt University since 2019. Previously, he held roles including Senior Researcher at the German Climate Computing Center (2016–2019), Postdoc at the University of Hamburg (2017–2019), and completed his Habilitation in Scientific Computing at TU Munich (2019). He transitioned to DESY/Universität Hamburg in May 2024. Education : PhD (Dr. rer. nat.) in Scientific Computing at TU Munich (2008–2013) Habilitation in Scientific Computing at TU Munich (2019) Studies in Technomathematics at Friedrich-Alexander University Erlangen-Nuremberg (2003–2008) Research Interests focus on high-performance computing, parallel and distributed systems, computational science, and applications in climate modeling. His work bridges computational methods with medical challenges, including surgical simulation training, wound healing mechanisms, and gastrointestinal pathology. Professional Activities include leadership roles in major conferences such as steering committee member for ISPDC (since 2021) and program committee roles in IPDPS, ICCS, and IEEE Cluster. He also managed the DFG priority program SPPEXA (2013–2016). Labs/Teams include the Chair for High-Performance Computing at Helmut Schmidt University and collaborations with the German Climate Computing Center. His current work at DESY/Universität Hamburg likely expands these computational efforts into interdisciplinary research.

Jason Yiمشاهده پروفایل

استادیار

• Neuroscience
• Molecular Neuroscience
• Developmental Neuroscience
• +۶ مورد دیگر

Dr. Jason Yi is an Assistant Professor of Neuroscience at Washington University School of Medicine (WashU Medicine). His research focuses on understanding the molecular pathways that shape nervous system development and function, with particular emphasis on autism spectrum disorders (ASD). He leads the Yi Lab, which investigates the role of the ubiquitin ligase UBE3A in the brain and its implications for neurodevelopmental disorders. Dr. Yi received his BS in Biochemistry and Molecular Biology from Dickinson College in 2001 and his PhD in Pharmacology from Duke University in 2009. His laboratory is broadly interested in the molecular pathways that shape nervous system development and function, with the ultimate goal of understanding how dysfunction in these pathways contributes to disease. The current focus is on autism spectrum disorders (ASD), using genetic information from human patients to guide in vitro and in vivo experiments employing biochemical, genetic manipulation, cell biological, and microscopy techniques. Dr. Yi's research has significant clinical implications, particularly in understanding how UBE3A dysfunction relates to both Angelman syndrome (caused by lack of UBE3A activity) and autism (caused by excessive UBE3A activity). His lab discovered that a single phosphorylation event in UBE3A turns off its ubiquitin ligase activity, and that mutations in this site are linked to autism. This work bridges disease genetics with a mechanistic understanding of ASD neurobiology and aims to define developmental timepoints for ASD onset. Dr. Yi's research has been recognized with numerous prestigious awards: Ruth K. Broad Biomedical Research Foundation Predoctoral Fellowship (2006) F32 Kirschstein National Research Service Award (2011) Christina Castellana Postdoctoral Fellowship (2011-2014) The University of North Carolina Postdoctoral Award for Research Excellence (2015) Bridge to Independence Award, The Simons Foundation (2017) NARSAD Young Investigator Award, Brain and Behavior Research Foundation (2018) Whitehall Foundation Research Grant (2018) Alfred P. Sloan Foundation Research Fellowship (2019) Dr. Yi's research program is supported by significant grant funding from organizations including The Simons Foundation, Brain and Behavior Research Foundation, and the Whitehall Foundation. His work bridges basic molecular neuroscience with clinical implications for neurodevelopmental disorders, particularly autism spectrum disorders. Through his research, Dr. Yi is contributing to a deeper understanding of the molecular mechanisms underlying ASD, which may ultimately lead to new therapeutic approaches and interventions. The Yi Lab maintains a collaborative research environment focused on cutting-edge neuroscience techniques. The lab combines molecular, cellular, and genetic approaches to study UBE3A function and its role in neurodevelopment. Their work utilizes patient-derived genetic information to guide experimental approaches, ensuring clinical relevance to autism spectrum disorders. Dr. Yi is also actively involved in mentoring graduate students and postdoctoral fellows, contributing to the training of the next generation of neuroscientists.

Stacy L. Pinelesمشاهده پروفایل

استاد

• Pediatric Ophthalmology
• Neuro-Ophthalmology
• Strabismus
• +۵ مورد دیگر

Stacy L. Pineles, MD, MS is a Professor of Ophthalmology and Residency Program Director at the Stein Eye Institute, David Geffen School of Medicine at the University of California, Los Angeles (UCLA). She also serves as Chair-Elect of the Pediatric Eye Disease Investigator Group (PEDIG), a collaborative network funded by the National Eye Institute dedicated to facilitating multicenter clinical research in strabismus, amblyopia, and other eye disorders affecting children. Dr. Pineles is affiliated with Ronald Reagan UCLA Medical Center and UCLA Santa Monica Medical Center as hospital affiliations. Dr. Pineles completed her medical training at the University of Pennsylvania in 2004, followed by ophthalmology residency at UCLA (2005-2008), pediatric ophthalmology fellowship at UCLA (2009), neuro-ophthalmology fellowship at the University of Pennsylvania (2010), and a Master's degree in Clinical Investigation at UCLA (2013). She joined the UCLA faculty in 2010 and became Residency Program Director in 2017. Her primary research interests focus on pediatric neuro-ophthalmology and strabismus, with specific emphasis on binocular vision in children and adults with eye misalignment, systemic effects of pediatric eye disease, and clinical trials in pediatric ophthalmology. Dr. Pineles serves as principal investigator of an NIH-sponsored multicenter study of pediatric optic neuritis. She runs an NIH-sponsored research program evaluating binocular vision in children and adults with eye misalignment. Analysis of Dr. Pineles' publications reveals consistent research activity in pediatric ophthalmology, neuro-ophthalmology, and strabismus, with particular focus on binocular vision, optic neuritis, and surgical outcomes. Her work spans clinical trials, diagnostic accuracy studies, and innovative surgical techniques, demonstrating expertise in both clinical care and research methodology. Super Doctors® Southern California, 2022-2025 AAPOS Young Investigator Award, 2019 University of California OptumLabs Research Credit Award, 2018 Appointment of Jerome and Joan Snyder Chair in Ophthalmology, 2017 American Academy of Ophthalmology Achievement Award, 2016 AAPOS Honors Award, 2016 Dr. Pineles serves on numerous professional committees within the American Academy of Ophthalmology, American Association of Pediatric Ophthalmology and Strabismus, and the North American Neuro-Ophthalmology Society. She travels regularly nationally and internationally to speak on topics related to her research in pediatric neuro-ophthalmology. As Residency Program Director since 2017, she oversees ophthalmology training at UCLA. She is author of more than 100 peer-reviewed publications and 10 book chapters. Dr. Pineles leads the Pediatric Ophthalmology division at the Stein Eye Institute, which is part of one of the world's leading centers of vision science. Her research program includes multicenter clinical trials and NIH-sponsored studies evaluating binocular vision and pediatric optic neuritis. She actively collaborates with the Pediatric Eye Disease Investigator Group (PEDIG), a network of over 100 participating sites with more than 300 pediatric ophthalmologists and optometrists across the United States, Canada, and the United Kingdom.

Praveen Bhugraمشاهده پروفایل

مدرس ارشد

• Cardiovascular Pharmacology
• Central Nervous System Pharmacology
• Autonomic Pharmacology
• +۲ مورد دیگر

Dr. Praveen Bhugra is a Senior Lecturer in Pharmacology at the University of Sunderland , where he has taught graduate courses including MPharm since 2006. His expertise spans cardiovascular, central nervous system, and autonomic pharmacology with a focus on receptor regulation in disease states. MSc (Pharmacology) from The Maharaja Sayajirao University of Baroda, India PhD (Medical Pharmacology) from Sardar Patel University, India His research integrates experimental pharmacology, molecular techniques (cell culture, calcium flux analysis), and biochemical approaches. Notably, he supervised PhD candidate Thomas Cherian (awarded 2014) on ureteral motility mechanisms. He authored the widely used textbook MCQs in Pharmacology (2000) and contributed to cardiovascular research during a 2000-2001 Visiting Scientist fellowship at the Institute of Cardiovascular Research, University of Manitoba, Canada. Recent publications (2015-2001) emphasize neurodegenerative pharmacology , hypertension mechanisms , and lipid mediator roles in cardiovascular disease . His work has been recognized with awards from the Indian Pharmacological Society and the International Society for Heart Research. Jaypur Prize (1985-86) C.L. Malhotra Research Prize (1994) Ahmedabad Branch Prizes (1996, 2001) National Academy of Medical Sciences Membership (2000) He has also contributed to public health research on probiotics in Clostridium difficile infection and participated in systematic reviews of substance abuse patterns in youth. Contact: praveen.bhugra@sunderland.ac.uk

Guillaume Chanfreauمشاهده پروفایل

استاد

• RNA metabolism
• RNA splicing
• RNA decay pathways
• +۵ مورد دیگر

Guillaume Chanfreau is a Professor in the Department of Chemistry and Biochemistry within the College of Letters and Science at the University of California Los Angeles (UCLA). His research focuses on fundamental mechanisms of RNA metabolism, with particular emphasis on RNA splicing, decay pathways, and ribonuclease functions. His work spans molecular biology, biochemistry, and genetics, utilizing yeast as a primary model organism to investigate conserved RNA processing mechanisms. Professor Chanfreau's research interests center on understanding how RNA processing pathways regulate gene expression. His work examines transcription termination, RNA splicing fidelity, RNA decay mechanisms, and the role of ribonucleases in cellular RNA homeostasis. He investigates how these processes are interconnected and how they respond to cellular stress conditions. His laboratory has made significant contributions to understanding how RNA quality control mechanisms prevent the accumulation of aberrant transcripts and maintain cellular health. Analysis of Chanfreau's recent publications (2020-2025) reveals a strong focus on RNA splicing mechanisms, RNA decay pathways, and ribonuclease functions. His work frequently employs yeast genetics combined with advanced RNA sequencing techniques. A notable trend is the increasing use of long-read sequencing technologies to analyze RNA isoforms and decay intermediates. His research consistently bridges fundamental molecular mechanisms with potential implications for understanding human diseases related to RNA processing defects. Professor Chanfreau has been continuously funded by the National Institutes of Health, with his current grant R35GM130370 (2019-2023) titled 'The Control of Gene Expression by Eukaryotic Ribonucleases' and previous long-term funding through R01GM061518 (2000-2019). His research program has supported numerous graduate students and postdoctoral researchers who have contributed to his extensive publication record spanning over two decades.

Baoyu Chenمشاهده پروفایل

دانشیار

• Cell Biology
• Structural Biology
• Biochemistry
• +۳ مورد دیگر

Baoyu Chen is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Digestive and Liver Diseases. He holds a bachelor's degree in chemical engineering from Hunan University (China), a master's in biochemistry and molecular biology from Tsinghua University (China), and a doctorate in chemical biology from Pennsylvania State University (USA). His research integrates biochemical, biophysical, computational, and structural approaches to investigate molecular mechanisms linking membrane signaling to cytoskeletal dynamics. Education: BSc in Chemical Engineering, Hunan University, China MS in Biochemistry & Molecular Biology, Tsinghua University, China PhD in Chemical Biology, Pennsylvania State University, USA Research Interests: Dr. Chen’s work focuses on protein assemblies regulating actin polymerization and endosomal trafficking (WAVE, WASH, CCC-Retriever, Retromer complexes) and their roles in cellular processes like migration, adhesion, immune activation, and neural development. His lab employs cryo-electron microscopy and collaborations with clinicians to uncover disease mechanisms. Recent Research Trends: His publications emphasize structural insights into WAVE complex activation, endosomal trafficking regulation, and pathogen hijacking of cytoskeletal systems. These studies span cell biology, structural biology, and synthetic biology applications. Scientific Awards: His work is supported by prestigious grants including the NIH MIRA NSF CAREER Award Professional Affiliations: Active member of American Heart Association American Society for Cell Biology Society for Neuroscience Laboratory: The Stone Chen Lab at UT Southwestern investigates membrane-to-cytoskeleton signaling and its implications in human disease. The lab collaborates with biologists and clinicians and welcomes opportunities for collaboration.

Jenny PY Tingمشاهده پروفایل

استاد

• Innate Immunity
• Immunology
• Inflammation
• +۷ مورد دیگر

Jenny PY Ting, PhD, is the William R. Kenan, Jr. Distinguished Professor of Genetics at the UNC School of Medicine and a member of the UNC Lineberger Comprehensive Cancer Center. She serves as Director of the Center for Translational Immunology and Co-Director of the Inflammatory Diseases Institute. Her research focuses on innate immunity, inflammation, and the molecular mechanisms underlying autoimmune diseases, cancer, and neuroinflammation. Dr. Ting's lab investigates the NLR protein family, particularly their roles in inflammasome activation, MHC regulation, and microbial sensing. She has discovered critical functions of NLRC5 and CIITA in immune gene transcription and pioneered studies on plexin-semaphorin signaling in immune cell interactions. Her work on SARS-CoV-2 revealed necroptosis-driven cell death cascades in airway cells, informing therapeutic strategies against cytokine storms. Key Projects: Microbiome-based therapies for multiple sclerosis Targeting NLRP3 inflammasomes in inflammatory diseases Role of plexins in T cell activation and sepsis Awards: National Academy of Sciences member (2022), AAI Distinguished Fellow (2023), ICIS-Pfizer Award (2021). Her lab employs cutting-edge techniques including transcriptomics, proteomics, and murine models. Collaborations span virology, oncology, and neurobiology, with translational goals for immune-based therapies.

• Neurosciences
• Physiology
• Microbiology
• +۵ مورد دیگر

Professor Elisa Hill is a distinguished academic at RMIT University where she serves as a Professor in the Department of Health and Biomedical Sciences within the College of Science. She leads the Gut-Brain Axis Laboratory and holds the significant position of Deputy Chair of the Academic Board at RMIT University. Her career spans prestigious institutions including The University of Melbourne and research collaborations in Paris, France. Professor Hill earned her PhD in Neuroscience from The University of Melbourne in 2002. She subsequently undertook a CNRS postdoctoral position in Paris studying cortical neuronal diversity. Returning to Melbourne in 2006 as an NHMRC Howard Florey Centenary Fellow, she joined Prof Steve Petrou's laboratory to investigate neuronal networks in genetic mouse models of epilepsy. In 2009, she imported the Neuroligin-3R451C mouse model of autism to Australia, establishing herself as a pioneer in gut-brain axis research. Her research program focuses on three interconnected areas: identifying causes of gut dysfunction in transgenic mouse models of neurological disease, determining how neurons communicate with the lymphoid system and inflammation, and understanding interactions between the nervous system and bacteria. Professor Hill has demonstrated that gene variations associated with autism alter neuron populations in the mouse enteric nervous system, affecting gut motility, permeability, microbiome composition, and behavior. Her laboratory has developed sophisticated capabilities including video-imaging assays for gut motility, immunofluorescence for neuronal and immune cell analysis, and whole-cell patch clamp electrophysiology for neuronal activity profiling. Analysis of her recent publications reveals a strong focus on the gut-brain axis in autism, with particular attention to the Neuroligin-3R451C mouse model. Her work spans neuroimmunology, gastrointestinal physiology, microbiome interactions, and behavioral neuroscience, demonstrating an increasingly interdisciplinary approach that integrates molecular, cellular, and systems-level perspectives. A notable trend is the expansion of her research into translational applications, including biomaterial development for urogynaecological health. NHMMRC Howard Florey Centenary Fellowship ARC Future Fellowship RMIT Senior Vice Chancellor's Research Fellowship Professor Hill actively supervises numerous PhD students including Vic Lin, Yuansong Li, and Mohammed Al Alamoudi, among others. Her research has been supported by major funding bodies including NHMRC, US Department of Defense CDMRP, CNRS, ARC, and RMIT. She leads the Gut-Brain Axis Laboratory, which collaborates extensively with researchers across institutions, particularly with Prof Ashley Franks at La Trobe University. The laboratory employs a multidisciplinary team with expertise in neuroscience, microbiology, immunology, and gastrointestinal physiology, utilizing advanced techniques to investigate the complex interactions between the nervous system, immune system, and gut microbiome.

Ece Gençمشاهده پروفایل

استاد

• Pharmacology
• Neuroscience
• Genetics
• +۵ مورد دیگر

Prof. Ece Genç is a distinguished academic at Yeditepe University's Faculty of Medicine, Department of Clinical Pharmacology. With a career spanning over four decades, she has held faculty positions at Istanbul University (1974-2004) and visiting roles at institutions like the National Institutes of Health (1989) and University of California, Irvine (1982). Education : B.Sc. in Chemical Engineering, Boğaziçi University (1973) Ph.D. in Pharmacology, Istanbul University (1977) Her research focuses on neuropharmacology , genetic influences on drug response , and metabolic-neurological interactions . Key areas include opioid-dopamine-GABA pathways, statin therapy variability, and genetic risk factors for sleep apnea and obesity. Her work bridges clinical pharmacology , neuroscience , and genetics through animal models and population studies. Her recent publications analyze warfarin dosing (2019), obesity genetics (2017-2018), and oxidative stress in diabetes (2010). These studies span SCI/SSCI journals , emphasizing pharmacogenomics and translational research. Scientific Awards : Service Award, Istanbul University (for 40+ years in pharmacology) Contributions to Turkish Pharmacology Association Prof. Genç has supervised 5+ theses, led 3+ grants (e.g., TÜBİTAK 1003 project), and authored 4+ books. She served as Head of Clinical Pharmacology at Yeditepe University (2005) and collaborated with Max-Planck Institute (1979).

Joanne Martinمشاهده پروفایل

استاد

• Pathology
• Gastrointestinal Motility Disorders
• Neuromuscular Disorders
• +۴ مورد دیگر

Joanne Martin is a Professor of Pathology at Queen Mary University of London and Deputy Vice Principal (Health). She holds affiliations with the Centre for Genomics and Child Health and serves as Chair of the BSc Experimental Pathology program. Her career spans clinical practice, research, education innovation, and national healthcare leadership. Education: MA from Cambridge University, MB BS from London Hospital Medical College, PhD from University of London, Masters in Leadership Research focuses on gastrointestinal neuromuscular disorders, particularly dysmotility pathogenesis and genetics. She also investigates digital education systems, digital pathology, and laboratory information management interoperability. Recent publications address chronic rectal dilatation pathways (2021), intestinal dysmotility guidelines (2020), and aging-related colon neuromuscular changes (2019). Key leadership roles include National Specialty Advisor for Pathology (NHS England/Improvement), former Royal College of Pathologists President (2017-2020), and Barts Health NHS Trust Director (5 years). She co-founded Biomoti (drug delivery company) and leads RCPath's adaptive learning program for Health Education England. Clinical expertise lies in gastrointestinal motility disorders. She contributed to digital pathology systems development and volunteered as a vaccinator during the pandemic. Awards recognize her eCPD app innovations and professional leadership.